US Fertility Clinics Price Exclusive Sperm Donor Access at $70,000 as Demand Rises

Sperm banks now segment the market by exclusivity and identity disclosure. Traditional vials remain under $2,000, yet premium contracts restrict distribution to as few as one family worldwide and add direct donor-parent contact. These terms respond to documented growth: donor-sperm IVF cycles rose from 5.6 percent in 2014 to 8.8 percent in 2022, coinciding with an increase from 87,000 to 151,000 female same-sex couples raising minor children. Providers capture willingness to pay for reduced half-sibling risk and future information rights.

The United States maintains no national donor registry, so contractual limits apply only within each bank. A donor may sell elsewhere, undermining exclusivity claims. This regulatory gap creates the price premium while capping verifiable control. State-level reporting remains fragmented, leaving families to bear information asymmetry costs that centralized tracking would otherwise internalize.

Market data indicate continued expansion. IVF births reached 100,158 in 2024. Absent federal registry legislation, banks will likely extend tiered pricing to additional genetic and contact options. Revenue growth hinges on sustained demand from single women and same-sex couples rather than regulatory change.

Next, clinics may bundle legal agreements and genetic screening into higher fixed packages. Volume growth in exclusive contracts will test whether banks can maintain scarcity claims without cross-bank coordination.